Crescent Biopharma, Inc. (CBIO)
NASDAQ · Healthcare
Crescent Biopharma, Inc. Revenue 2012–2025
Crescent Biopharma, Inc. annual/quarterly revenue history and growth rate from 2012 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Crescent Biopharma, Inc. revenue for the quarter ending March 31, 2026 was 1.0 M.
- Crescent Biopharma, Inc. revenue for the twelve months ending March 31, 2026 was 1.2 M, a 89.14% decrease year-over-year.
- Crescent Biopharma, Inc. annual revenue for 2025 was 10.8 M, a 108340.00% increase from 2023.
- Crescent Biopharma, Inc. annual revenue for 2023 was 10000, a 86.67% decrease from 2022.
- Crescent Biopharma, Inc. annual revenue for 2022 was 75000, a 93.53% decrease from 2021.
- Crescent Biopharma, Inc. annual revenue for 2021 was 1.2 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Crescent Biopharma, Inc. Revenue — FAQ
Crescent Biopharma, Inc. (CBIO) revenue over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
What is Crescent Biopharma, Inc.'s revenue?
Crescent Biopharma, Inc. (CBIO) reported revenue of $11M for fiscal 2025.
Where can I see CBIO's revenue history?
The chart and table above show Crescent Biopharma, Inc.'s revenue by year and by quarter, including the growth rate.